Clinical Trials Directory

Trials / Unknown

UnknownNCT03121053

Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement

Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
St. Antonius Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Chronic kidney disease (CKD) and (subsequent) acute kidney injury are frequent in patients undergoing transcatheter aortic valve implantation (TAVI). Moreover, these patients are easily hypervolemic and susceptible for cardiac decompensation. Prevention of contrast induced nephropathy (CIN) has not yet been studied in these patients, and evidence on different strategies is urgently needed. The objective of this study is to evaluate the efficacy of 250ml 1.4% sodium bicarbonate versus hypotone saline (0.65% sodiumchloride) hydration prior to TAVI in patients with CKD to prevent CIN.

Conditions

Interventions

TypeNameDescription
DRUGsodium bicarbonate
DRUGhypotone saline

Timeline

Start date
2016-10-01
Primary completion
2018-12-01
Completion
2019-01-01
First posted
2017-04-19
Last updated
2017-04-19

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03121053. Inclusion in this directory is not an endorsement.